Safety study of CVL-231 (Emraclidine) in schizophrenia
This study was terminated in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 13 sites
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Sofia, Sofia-GradSofia, Sofia-GradSite status: Not listed — confirm with the team
- Pazardzhik, PazardzhikPazardzhikSite status: Not listed — confirm with the team
- Pleven, PlevenPlevenSite status: Not listed — confirm with the team
- Sliven, SlivenSlivenSite status: Not listed — confirm with the team
- Stara Zagora, Stara ZagoraStara ZagoraSite status: Not listed — confirm with the team
- Varna, VarnaVarnaSite status: Not listed — confirm with the team
- Veliko Tarnovo, Veliko TarnovoVeliko TarnovoSite status: Not listed — confirm with the team
- Vratsa, VratsaVratsaSite status: Not listed — confirm with the team
Hungary · 2 sites
- Kalocsa, Bács-KiskunKalocsa, Bács-Kiskun countySite status: Not listed — confirm with the team
- Gyor, Gyor-Moson-SopronGyőr, Győr-Moson-SopronSite status: Not listed — confirm with the team
Puerto Rico · 2 sites
- San Juan, Puerto RicoSan JuanSite status: Not listed — confirm with the team
- San Juan, Puerto RicoSan JuanSite status: Not listed — confirm with the team
Ukraine · 6 sites
- Ivano Frankivsk, Ivano FrankivskIvano-Frankivsk, Ivano-Frankivsk OblastSite status: Not listed — confirm with the team
- Lviv, L'vivs'ka OblastLviv, Lviv OblastSite status: Not listed — confirm with the team
- Kropyvnytskyi, KropyvnytskyiKropyvnytskyiSite status: Not listed — confirm with the team
- Kyiv, KyïvKyivSite status: Not listed — confirm with the team
- Smila, SmilaSmilaSite status: Not listed — confirm with the team
- Vinnytsia, VinnytsiaVinnytsiaSite status: Not listed — confirm with the team
United States · 62 sites
- Phoenix, ArizonaPhoenix, ArizonaSite status: Not listed — confirm with the team
- Bryant, ArkansasBryant, ArkansasSite status: Not listed — confirm with the team
- Little Rock, ArkansasLittle Rock, ArkansasSite status: Not listed — confirm with the team
- Anaheim, CaliforniaAnaheim, CaliforniaSite status: Not listed — confirm with the team
- Bellflower, CaliforniaBellflower, CaliforniaSite status: Not listed — confirm with the team
- Culver City, CaliforniaCulver City, CaliforniaSite status: Not listed — confirm with the team
- Garden Grove, CaliforniaGarden Grove, CaliforniaSite status: Not listed — confirm with the team
- La Habra, CaliforniaLa Habra, CaliforniaSite status: Not listed — confirm with the team
- Lemon Grove, CaliforniaLemon Grove, CaliforniaSite status: Not listed — confirm with the team
- Montclair, CaliforniaMontclair, CaliforniaSite status: Not listed — confirm with the team
- Orange,CaliforniaOrange, CaliforniaSite status: Not listed — confirm with the team
- Pico Rivera, CaliforniaPico Rivera, CaliforniaSite status: Not listed — confirm with the team
- Riverside, CaliforniaRiverside, CaliforniaSite status: Not listed — confirm with the team
- San Diego, CaliforniaSan Diego, CaliforniaSite status: Not listed — confirm with the team
- San Diego, CaliforniaSan Diego, CaliforniaSite status: Not listed — confirm with the team
- San Diego, CaliforniaSan Diego, CaliforniaSite status: Not listed — confirm with the team
- Sherman Oaks, CaliforniaSherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Torrance, CaliforniaTorrance, CaliforniaSite status: Not listed — confirm with the team
- Walnut Creek, CaliforniaWalnut Creek, CaliforniaSite status: Not listed — confirm with the team
- New Haven, ConnecticutNew Haven, ConnecticutSite status: Not listed — confirm with the team
- Bonita Springs,FloridaBonita Springs, FloridaSite status: Not listed — confirm with the team
- Fort Myers, FloridaFort Myers, FloridaSite status: Not listed — confirm with the team
- Hialeah, FloridaHialeah, FloridaSite status: Not listed — confirm with the team
- Hialeah, FloridaHialeah, FloridaSite status: Not listed — confirm with the team
- Miami, FloridaMiami, FloridaSite status: Not listed — confirm with the team
- Miami, FloridaMiami, FloridaSite status: Not listed — confirm with the team
- Miami, FloridaMiami, FloridaSite status: Not listed — confirm with the team
- Miami Lakes, FloridaMiami Lakes, FloridaSite status: Not listed — confirm with the team
- Miami Lakes, FloridaMiami Lakes, FloridaSite status: Not listed — confirm with the team
- Miami Springs, FloridaMiami Springs, FloridaSite status: Not listed — confirm with the team
- Oakland Park, FloridaOakland Park, FloridaSite status: Not listed — confirm with the team
- West Palm Beach, FloridaWest Palm Beach, FloridaSite status: Not listed — confirm with the team
- Atlanta, GeorgiaAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Atlanta, GeorgiaAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Atlanta, GeorgiaAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Decatur, GeorgiaDecatur, GeorgiaSite status: Not listed — confirm with the team
- Savannah,GeorgiaSavannah, GeorgiaSite status: Not listed — confirm with the team
- Berwyn, IllinoisBerwyn, IllinoisSite status: Not listed — confirm with the team
- Chicago, IllinoisChicago, IllinoisSite status: Not listed — confirm with the team
- Chicago, IllinoisChicago, IllinoisSite status: Not listed — confirm with the team
- Chicago, IllinoisChicago, IllinoisSite status: Not listed — confirm with the team
- Chicago, IllinoisChicago, IllinoisSite status: Not listed — confirm with the team
- Chicago, IllinoisChicago, IllinoisSite status: Not listed — confirm with the team
- Marrero, LouisianaMarrero, LouisianaSite status: Not listed — confirm with the team
- Shreveport, LouisianaShreveport, LouisianaSite status: Not listed — confirm with the team
- Gaithersburg, MarylandGaithersburg, MarylandSite status: Not listed — confirm with the team
- Flowood, MississippiFlowood, MississippiSite status: Not listed — confirm with the team
- Las Vegas, NevadaLas Vegas, NevadaSite status: Not listed — confirm with the team
- Berlin, New JerseyBerlin, New JerseySite status: Not listed — confirm with the team
- Cedarhurst, New YorkCedarhurst, New YorkSite status: Not listed — confirm with the team
- New York, New YorkNew York, New YorkSite status: Not listed — confirm with the team
- Staten Island, New YorkStaten Island, New YorkSite status: Not listed — confirm with the team
- Charlotte, North CarolinaCharlotte, North CarolinaSite status: Not listed — confirm with the team
- North Canton, OhioNorth Canton, OhioSite status: Not listed — confirm with the team
- Oklahoma City, OklahomaOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Franklin,TennesseeFranklin, TennesseeSite status: Not listed — confirm with the team
- Austin, TexasAustin, TexasSite status: Not listed — confirm with the team
- DeSoto, TexasDeSoto, TexasSite status: Not listed — confirm with the team
- Houston, TexasHouston, TexasSite status: Not listed — confirm with the team
- Houston, TexasHouston, TexasSite status: Not listed — confirm with the team
- Plano, TexasPlano, TexasSite status: Not listed — confirm with the team
- Richardson, TexasRichardson, TexasSite status: Not listed — confirm with the team
Key information made simple
What is this study testing?
This study is testing whether Emraclidine 30 mg may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Emraclidine 30 mg, attend study visits with the research team. The registry lists locations in Bulgaria, in Hungary, and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 698
- Sponsor
- AbbVie
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Bulgaria, Hungary, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05443724
- Official title
- A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia
- Official source
- Official registry link
Want help reviewing this study?
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Emraclidine 30 mg. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
